The latter two cancer cell lines are different in term of the status of three key receptors conventionally used for breast cancer subtyping, which are estrogen receptor (ER), progesterone receptor (PR) and human epithelial receptor 2 (HER2) [13]. This evidence concerns the gene PGR and breast carcinoma.